Industries > Pharma > Aortic Aneurysm Market Report 2021-2031

Aortic Aneurysm Market Report 2021-2031

Forecasts by Type (TAA, AAA), by Product (Stent Grafts, Catheters), by Treatment (EVAR, OSR), by End User (Hospitals & Clinics, ASCs) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Aortic Aneurysm Companies AND COVID-19 Recovery Scenarios

PUBLISHED: 21 April 2021
PAGES: 364
PRODUCT CODE: PHA0559
SUBMARKET: Medical Devices

Clear
WOOCS 2.2.1
SKU: PHA0559 Categories: , Tags: ,

Aortic Aneurysm Market – shows you the latest trends & dynamics, opportunities, and competitive analysis. Read on to exploit the impending revenue pockets emerging in this sector along with detailed COVID-19 recovery scenarios.

Our 364-page report provides 289 tables and charts/graphs. Read on to learn the most lucrative segments in the industry and the future market prospects. Our new study lets you evaluate forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Aortic Aneurysm Market. See how to exploit the opportunities.

COVID 19 Impact & Recovery Analysis on the Market
The ongoing COVID-19 pandemic places a great burden on the world’s healthcare systems and even the most established hospitals are forced to review their treatment options. Because of the lack of ICU beds available, most medical centers have completely limited or discontinued elective surgical procedures. In the unfortunate case of a AAA ruptured (rAAA) and/or concomitant COVID-19 infection, endovascular repair is undoubtedly a treatment choice identified in other recent directives.

UNIQUE COVID-19 VARIATIONS– only available in this Visiongain report are dedicated analysis of 4 different rebound scenarios of how the market will develop – no matter how COVID-19 affects the economy.

To access the data contained in this document please email contactus@visiongain.com

Which Factors are Fueling Aortic Aneurysm Industry Growth?
• Rise in geriatric population
• High tobacco smoking prevalence in the developed and developing nations
• Prevalence of cardiovascular disease in adults
• Growing emphasis on the benefits of AAA screening

Which Factors are Restraining Growth?
• Expensive surgical repair of AAA
• Inadequate reimbursement for each reintervention after EVAR

What are Market Opportunities?
• Aneurysms previously considered inoperable can be repaired by new 3D technology
• Innovative AAA devices provide patients and physicians with a new, less invasive option

Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and submarkets
Brazil, Mexico, and rest of Latin America markets are studied as the major markets under Latin America region. A multitude of developing countries make up Latin America. Nearly 600 million people are undergoing demographic shifts, in which rapid population growth is combined with a gradual ageing of the people. For general and cardiovascular health, this part of the globe presents great challenges. There are substantial or even higher rates of cardiovascular diseases or exposure to risk in most countries.

Abdominal aortic aneurysm (AAA) segment dominated the Latin America aortic aneurysm market by type and is projected to witness CAGR of 8.3% during the first half of the forecast period i.e., 2021 to 2026. Visiongain anticipates that Thoracic aortic aneurysm (TAA) segment will witness fastest growth rate of 9.3% during the forecast period i.e., 2021 to 2031.

CTA

Report Scope
Global aortic aneurysm market 2021-2031 is segmented on the basis of type, product, treatment, end user and geography.

Aortic Aneurysm Market: By Type
• Thoracic Aortic Aneurysm (TAA)
• Abdominal Aortic Aneurysm (AAA)

Aortic Aneurysm Market: By Product
• Stent Grafts
• Catheters

Aortic Aneurysm Market: By Treatment
• Endovascular Aneurysm Repair (EVAR)
• Open Surgical Repair (OSR)

Aortic Aneurysm Market: By End User
• Hospitals & Clinics
• Ambulatory Surgery Centers (ASCs)

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 15 leading national markets:
• North America
• U.S.
• Canada

• Europe
• Germany
• France
• UK
• Italy
• Spain
• Rest of Europe

• Asia Pacific
• China
• Japan
• India
• Australia
• Rest of Asia Pacific

• Latin America
• Brazil
• Mexico
• Rest of Latin America

• Middle East & Africa
• GCC
• South Africa
• Rest of Middle East & Africa

Aortic Aneurysm Market Report 2021-2031
Need industry data? Please contact us today.

The report also includes profiles and for some of the leading companies in the aortic aneurysm market, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
Overall world revenue for Aortic Aneurysm Market will surpass $xx billion in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Aortic Aneurysm Market report helps you
In summary, our 360+ page report provides you with the following knowledge:

• Revenue forecasts to 2031 for Aortic Aneurysm Market, with forecasts for Type, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues. Abdominal aortic aneurysm (AAA) segment accounts for the major share of the global aortic aneurysm market in 2020 while thoracic aortic aneurysm (TAA) segment is expected to be the fastest growing market during the forecast period.

• Revenue forecasts to 2031 for Aortic Aneurysm Market, with forecasts for Product, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues. Stent grafts segment accounts for the major share of the global aortic aneurysm market in 2020 while catheters segment is expected to be the fastest growing market during the forecast period.

• Revenue forecasts to 2031 for Aortic Aneurysm Market, with forecasts for Treatment, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues. Endovascular aneurysm repair (EVAR) segment accounts for the major share of the global aortic aneurysm market in 2020 while open surgical repair (OSR) segment is expected to be the fastest growing market during the forecast period.

• Revenue forecasts to 2031 for Aortic Aneurysm Market, with forecasts for End User, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues. Hospitals & clinics segment accounts for the major share of the global aortic aneurysm market in 2020 while ambulatory surgery centers (ASCs) segment is expected to be the fastest growing market during the forecast period.

• Revenue forecasts to 2031 for 5 regional and 16 key national markets – See forecasts for the aortic aneurysm market in North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. Also forecasted is the market in the US, Canada, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, and Australia among other prominent economies. There will be growth in both established and in developing markets. Our analyses show that the U.S. would continue dominating the global aortic aneurysm market while India is poised to grow at a double digit CAGR during the forecast period, 2021 to 2031.

• Prospects for established firms and those seeking to enter the market– including company profiles for 14 of the major companies involved in the Aortic Aneurysm Market. Some of the company’s profiled in this report include:
• Medtronic plc
• Cardinal Health, Inc.
• W. L. Gore & Associates, Inc.
• Cook Medical
• JOTEC GmbH
• Terumo Corporation
• Cardiatis
• Endologix, Inc.
• Endospan
• LifeTech Scientific Corporation
• Getinge AB
• Arsenal Medical, Inc.
• Lombard Medical Limited

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Aortic Aneurysm Market and leading companies. You will find data, trends and predictions.

To access the data contained in this document please email contactus@visiongain.com

Buy our report today Aortic Aneurysm Market Report 2021-2031: Forecasts by Type (TAA, AAA), by Product (Stent Grafts, Catheters), by Treatment (EVAR, OSR), by End User (Hospitals & Clinics, ASCs) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Aortic Aneurysm Companies AND COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Aortic Aneurysm Market Report 2021-2031


Download sample pages

Complete the form below to download your free sample pages for Aortic Aneurysm Market Report 2021-2031


Latest Pharma news

Visiongain Publishes Direct-to-Patient Market Report 2021-2031

Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.

21 July 2021

READ

Visiongain Publishes Drug Delivery Technologies Market Report 2021-2031

Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.

20 July 2021

READ

Visiongain Publishes Pharma Contract Sales Market Report 2021-2031

Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.

14 July 2021

READ

Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2021-2031

Digital innovation in clinical trials and renewed focus on home production will ensure a high growth market for supply chain optimisation.

12 July 2021

READ

Categories